Oral hypoglycemic agents.
D000284:Administration, Oral; D000818:Animals; D001645:Biguanides / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy; D004347:Drug Interactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050356:Lipid Metabolism; D010629:Phenformin / Q000494:pharmacology; D012306:Risk; D013268:Stimulation, Chemical; D013453:Sulfonylurea Compounds / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D010629:Phenformin